Newsroom

Sorted by: Latest

-

Rimini Street anuncia su participación en la 38.a Conferencia Anual para Inversores de ROTH Capital Partners

LAS VEGAS--(BUSINESS WIRE)--Rimini Street, Inc. (Nasdaq: RMNI), proveedor global de soporte integral de software empresarial, servicios gestionados y soluciones innovadoras de ERP con IA agéntica, y proveedor líder de soporte de terceros para software de Oracle, SAP y VMware, anunció hoy la siguiente Conferencia para Inversores de ROTH Capital Partners, que se celebrará los días 23 y 24 de marzo de 2026 en Laguna Niguel, California: Seth Ravin, CEO, y Dean Pohl, vicepresidente, tesorero y respo...
-

Andersen Consulting新增合作公司Milestone Technologies

旧金山--(BUSINESS WIRE)--(美国商业资讯)-- Andersen Consulting持续强化其数字化转型平台,新增总部位于美国的合作公司Milestone Technologies,该公司是一家久经考验的全球IT服务和数字解决方案提供商。 Milestone Technologies成立于1997年,提供端到端技术和外包解决方案,涵盖数字工作场所服务、云计算和基础设施管理、数据、AI和自动化、应用和数字工程、业务流程外包,以及ServiceNow和Salesforce平台实施。Milestone总部位于加州弗里蒙特,业务遍及全球35个国家,服务于多家全球大型企业。该公司的一体化交付模式助力客户实现IT运营转型、提升服务效率,并在全球范围内无缝扩展技术生态系统。 Milestone Technologies首席执行官Sameer Kishore表示:“Milestone Technologies是一家以员工为先的企业,凭借深厚的技术和流程专长,为各行各业的客户带来可衡量的业务成果,并加速客户的数字化转型。我们很高兴与Andersen Consulting开展合作,此次...
-

Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. announced today that the company has entered into a global license, development and commercialization agreement (DCA) with Sandoz for up to five biosimilar candidates under development by Samsung Bioepis, including SB36, a biosimilar candidate referencing Entyvio1 (vedolizumab). The other terms of the agreement remain confidential. Under the terms of the agreement, Samsung Bioepis will be responsible for development, regulatory registra...
-

Mexedia: l’Assemblée Générale Extraordinaire des Actionnaires approuve des modifications des statuts visant à renforcer la flexibilité financière de la Société

ROME--(BUSINESS WIRE)--Regulatory News : Mexedia S.p.A. Società Benefit (« Mexedia » ou la « Société »), société technologique italienne opérant à l’international dans les services et les technologies de communication entre entreprises et clients, cotée sur Euronext Growth Paris (ISIN IT0005450819 – ticker ALMEX), annonce que l’Assemblée Générale Extraordinaire des Actionnaires tenue le 13 mars 2026 a approuvé l’ensemble des modifications statutaires proposées visant à renforcer la flexibilité...
-

Mexedia: Extraordinary Shareholders’ Meeting Approves Amendments to the Articles of Association to Strengthen the Company’s Financial Flexibility

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (“Mexedia” or the “Company”), an Italian tech company operating internationally in services and technologies for communication between companies and customers, listed on Euronext Growth Paris (ISIN IT0005450819 – ticker ALMEX), announces that the Extraordinary Shareholders’ Meeting held on March 13, 2026 approved all the proposed amendments to the Articles of Association aimed at strengthening the Company’s financial and org...
-

Pershing Square Holdings, Ltd. UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 17 March 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 17 March 2026 Number of Public Shares Purchased: 30,990...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Mortimer 2025-1 PLC GBP 4,341,000.00 MATURING: 22-Sep-2070 ISIN: XS3196127420 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 27-Oct-2025 TO 23-Mar-2026 HAS BEEN FIXED AT 5.71 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: GBP 107,150.35 PER GBP 4,659,000.00 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: ORBITA FUNDING 2023-1 PLC GBP 32,664,000.00 MATURING: 22-Oct-2030 ISIN: XS2699151457 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 23-Feb-2026 TO 23-Mar-2026 HAS BEEN FIXED AT 6.53 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: GBP 163,714.47 PER GBP 32,664,000.00 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: MORTIMER BTL 2023-1 PLC GBP 5,124,000.00 MATURING: 22-Dec-2056 ISIN: XS2712035430 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 23-Mar-2026 HAS BEEN FIXED AT 10.44 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: GBP 14,381.92 PER GBP 552,397.84 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: MORTIMER BTL 2023-1 PLC GBP 3,895,000.00 MATURING: 22-Dec-2056 ISIN: XS2712035190 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 23-Mar-2026 HAS BEEN FIXED AT 9.60 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: GBP 98,158.93 PER GBP 4,100,000.00 DENOMINATION  ...